References in periodicals archive ?
the pioneer in scalable, high performance transient transfection systems, is pleased to announce that Paragon Bioservices has acquired both the MaxCyte VLX([R]) Large Scale Transfection System and the MaxCyte STX([R]) Scalable Transfection System for use in contract manufacturing of recombinant proteins, antibodies, viral vectors, vaccines, and VLPs.
Cells from these banks may be used in production of biopharmaceuticals such as monoclonal antibodies, viral vectors or recombinant DNA products.
The patent covers the use of PSA, PSMA, and PAP, inclusive of derivatives, peptides, anti-idiotypic antibodies, viral vectors and naked DNA.
Full browser ?